Fit for Everyday Life - Increasing Exercise and Physical Activity in Those Rehablilitating From Cancer

May 31, 2022 updated by: Turku University Hospital
The aim of the study is to increase the physical activity and exercise of those recovering from cancer (after treatments) and to promote a functional return to everyday life and coping in everyday life. The aim of the study is to evaluate the effects of a exercise intervention on the quality of life, functional fitness (functional muscle strength and endurance tests) and the amount of physical activity of the participants in the study.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Design: This is a quantitative study, whose data includes structured surveys (questionnaires) and measurements. Data are collected before and after the group exercise intervention. This 8 week tailored, progressive program will consist muscle strength training, endurance training, flexibility training, relaxation and home-exercises.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Active cancer treatments have ended under 12 months
  • Age 18-70 years
  • Finnish speaking
  • moving without aids
  • z=1-0
  • able to come Meri-Karina
  • normal or low physical activity
  • able to use digital equipments to participate remote exercise sessions

Exclusion Criteria:

  • Exercise contraindications
  • Memory and mental health problems
  • Exercise every day over two hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of Quality of life
Time Frame: change from baseline at 8 weeks
Eortec Qlqc-30
change from baseline at 8 weeks
The change of Functional muscle strength
Time Frame: change from baseline at 8 weeks
upper and lower body functionals muscle strength tests
change from baseline at 8 weeks
The change of Endurance
Time Frame: change from baseline at 8 weeks
6 min walking test
change from baseline at 8 weeks
The change of Subjective physical activity
Time Frame: change from baseline at 8 weeks
exercise diary
change from baseline at 8 weeks
The change of Subjective physical capability
Time Frame: change from baseline at 8 weeks
PROMIS-Cancer
change from baseline at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experiences and feedback
Time Frame: only at 8 weeks
subjective feedback survey
only at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Turku University Hospital

Collaborators

Lounais-Suomen Syöpäyhdistys

Investigators

  • Study Director: Pia Vihinen, MD, PhD, Turku University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2022

Primary Completion (Anticipated)

May 31, 2024

Study Completion (Anticipated)

May 31, 2024

Study Registration Dates

First Submitted

May 10, 2022

First Submitted That Met QC Criteria

May 31, 2022

First Posted (Actual)

June 3, 2022

Study Record Updates

Last Update Posted (Actual)

June 3, 2022

Last Update Submitted That Met QC Criteria

May 31, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • T0000/2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Survivor

Clinical Trials on Increasing Exercise and Physical Activity in Those Rehablilitating From Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe